Company intelligence / Profile preview

Ilhwa

Seoul, Seoul, South Koreailhwa-usa.com ↗

Ownership: Private
Development stage: Other

Overview

Ilhwa is a global leader in ginseng science with commercialized products based on enzyme-fermented Korean ginseng. Their products are supported by clinical studies and have received regulatory approval for health claims related to blood glucose management. The company collaborates with academic institutions for further research into the physiological effects of their products.

Therapeutic areas: NeurologyPsychiatryEndocrinologyOtherImmunology
Modalities: Small molecule (ginsenosides and other phytochemicals from ginseng)Herbal extract (Ginseng extract)
Industry: Food & Nutrition

Partnerships

Ohio State University Human Performance Laboratory research collaboration on ginseng’s effects on stress physiology and neurological aspects

Beyond the preview

Go deeper on Ilhwa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ilhwa.

Explore the full profile